HUM Q3 Earnings Beat Estimates on Strong Insurance Performance - Zacks Investment Research
HUM Q3 Earnings Beat Estimates on Strong Insurance Performance - Zacks Investment Research(摘要待生成)
Why Humana (HUM) Could Beat Earnings Estimates Again - Zacks Investment Research
Why Humana (HUM) Could Beat Earnings Estimates Again - Zacks Investment Research(摘要待生成)
Cowen Upgrades UNH and HUM Stocks to Buy and Lifts Price Targets After Healthcare Sell-Off. Here’s Why - TipRanks
Cowen Upgrades UNH and HUM Stocks to Buy and Lifts Price Targets After Healthcare Sell-Off. Here’s Why TipRanks
Humana (HUM) Q3 2026 Earnings Call Transcript
Humana (HUM) Q3 2026 Earnings Call Transcript(摘要待生成)
Humana lifts annual profit forecast as medical costs ease
Humana lifts annual profit forecast as medical costs ease(摘要待生成)
Humana 8-K (2.02, 7.01, 9.01): reported results of operations
Humana reported third-quarter 2026 GAAP EPS of $1.33 and adjusted loss per share of $0.70, and raised full-year 2026 guidance to at least $15.09 GAAP EPS and $9.50 adjusted EPS.
Humana drops 9% on proposed Medicare fraud crackdown (HUM:NYSE) - Seeking Alpha
Humana drops 9% on proposed Medicare fraud crackdown (HUM:NYSE) Seeking Alpha
Humana (NYSE:HUM) Shares Gap Up Following Analyst Upgrade
Humana (NYSE:HUM) Shares Gap Up Following Analyst Upgrade MarketBeat
Humana (NYSE:HUM) Stock Falls 9.1% - Here's Why
Humana (NYSE:HUM) Stock Falls 9.1% - Here's Why MarketBeat
Why is Humana stock sliding today? By Investing.com - Investing.com UK
Why is Humana stock sliding today? By Investing.com Investing.com UK
Humana 8-K (8.01, 9.01): other events
Humana set pricing terms for cash tender offers covering eight outstanding note series, with total consideration ranging from $852.68 to $1,005.77 per $1,000 principal, a $1.5 billion aggregate purchase cap, and an $800 million cap for its 5.375% notes due 2031.
Humana 8-K (8.01, 9.01): other events
Humana commenced cash tender offers for eight series of outstanding senior notes, subject to a $1.5 billion total purchase cap and an $800 million cap on its 5.375% notes due 2031, with acceptance prioritized across the series.